4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-006444
CHIEF COMMERCIAL OFFICER gave up 1,353 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 2,477 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-04-10 | Option exercise | +2,477 | 13,906 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-04-10 | Shares withheld for taxes | −1,353 | $10.71 | $14,491 | 12,553 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-04-10 | Option exercise · Restricted Share Unit | +2,477 | 7,431 | D | ||
Loading xslF345X04/form4-04112023_090434.xml…